-
admin
Posts
Aker Horizons ASA: Notice of Annual General Meeting
FORNEBU, Norway, April 4, 2025 /PRNewswire/ — The annual general meeting of Aker Horizons ASA (the “Company”) will be held on Wednesday, 30 April 2025 at...
BeLive Holdings Announces Pricing of Approximately $10,000,000 Initial Public Offering
SINGAPORE, April 4, 2025 /PRNewswire/ — BeLive Holdings (the “Company” or “BeLive”), a provider of live commerce and shoppable short videos solutions (“BeLive Solutions”) to...
KuCoin Achieves SOC 2 Type II Certification: Strengthening Security and Compliance Standards
VICTORIA, Seychelles, April 4, 2025 /PRNewswire/ — KuCoin, a leading global cryptocurrency exchange, has successfully completed its SOC 2 Type II audit, marking a significant...
Hakluyt appoints Kenichiro Yoshida to its International Advisory Board
LONDON, April 4, 2025 /PRNewswire/ — Hakluyt, the global strategic advisory firm for businesses and investors, has announced the appointment of Kenichiro Yoshida, executive chairman...
Shell to sell interest in Colonial Enterprises Inc. to Brookfield subsidiary
HOUSTON, April 4, 2025 /PRNewswire/ — Shell Midstream Operating LLC (SMUS), a subsidiary of Shell plc (“Shell”), has agreed to sell its 16.125% interest in...
ELF INVESTOR ALERT: Kirby McInerney LLP Notifies e.l.f. Beauty, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP reminds investors of the May 5, 2025, deadline to seek...
Pilly Labs Gummies Redefine Wellness with Science-Backed, Natural Supplements
From Cognitive Clarity to Joint Comfort, Pilly Labs Supplements Are Designed to Empower Modern Wellness with Transparency and Trust Chicago, April 03, 2025 (GLOBE NEWSWIRE)...
Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs
NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) — Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on...
Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit...
Anne Whitaker Appointed as Non-Executive Director
MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of...
